United States

U.S. Reviews CBD Amid Pressure to Act Quickly: Cannabis Weekly – Bloomberg

May 30, 2019

This is a step in the right direction.
The U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound can be included in food and drinks.
“What they might end up doing is reserve the higher dosages of CBD for pharmaceutical drugs and only permit lower dosages to be incorporated in food and drinks. That in itself would hopefully keep an incentive for the pharmaceutical companies to continue to invest in clinical research.”
The full story is here:
U.S. Reviews CBD Amid Pressure to Act Quickly: Cannabis Weekly – Bloomberg
Feature photo by Francesco Mazzone on Unsplash
SMALL_LEAF_2
 

Please follow and like us:

    Leave a Reply

    Instagram

    Follow Me!